Tech Company Financing Transactions
Moleculent Funding Round
On 4/30/2026, Moleculent raised $20 million in funding from Rubicon Venture Capital, Arch Venture Partners and Eir Ventures.
Transaction Overview
Company Name
Announced On
4/30/2026
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Scheeles Väg 1
Solna, 171 65
Sweden
Solna, 171 65
Sweden
Phone
Undisclosed
Website
Email Address
Overview
Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in life science. At the core of our work lies a deep-seated passion for advancing human health, and we always prioritize the needs and concerns of the scientists we serve. We firmly believe that open communication and data-driven decision-making are the keys to our ongoing success. Our ultimate goal is to surpass expectations by delivering the highest possible level of quality and excellence in everything we do. We know that innovation thrives in an environment of mutual respect, open dialogue, and shared joy, and that's precisely what we strive to cultivate each and every day.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Patrick Weiss
Chief Executive Officer
Olle Ericsson
Chief Technical Officer
Fredrik Roos
VP - Human Resources
Sara Jupiter
VP - Product Management
Florian Baumgartner
Browse more venture capital transactions:
Prev: 4/30/2026: Photon Health venture capital transaction
Next: 4/30/2026: Online Oceans venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs